GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Egetis Therapeutics AB (publ) EGTX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

11.12

0.00%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Egetis Therapeutics AB (publ) annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 62.4mSEK 46.1mSEK 57.6mSEK 22.5mSEK 38.2m
Operating income−SEK 346.9m−SEK 333.8m−SEK 324.7m−SEK 198.1m−SEK 105.7m
Net income−SEK 342.5m−SEK 343.6m−SEK 326.9m−SEK 189.5m−SEK 104.7m
Free cash flow−SEK 268.6m−SEK 227.9m−SEK 278.4m−SEK 173.5m−SEK 130.3m
Total assetsSEK 639.1mSEK 792.3mSEK 760.2mSEK 561.1mSEK 569.3m
Shareholders' equitySEK 338.7mSEK 492.8mSEK 545.6mSEK 506.2mSEK 527.0m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.